# Mesalazine

## Asacol 500mg suppository

##### 臨採

| TAH Drug Code      | [EASA](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EASA)                                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ulcerative colitis, mild to moderate proctitis, proctosigmoiditis.                                                                                                                                                                                                                                                                  |
| Dosing             | 1 ~ 2 suppository tid                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | No Data                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | No Data                                                                                                                                                                                                                                                                                                                             |
| Contraindications  | Infant <2 years. Severe renal impairment.                                                                                                                                                                                                                                                                                           |
| Adverse Effects    | Nausea, diarrhea, abdominal pain, headache, exacerbation of symptoms of colitis; rarely, blood disorders, pancreatitis, hepatitis. Gastrointestinal: Diarrhea (up to 8% ), Flatulence (0.7% to 4% ), Nausea (2.8% to 4% ), Upper abdominal pain (5%) Neurologic: Headache (3.4% to 11% ) Respiratory: Nasopharyngitis (1.4% to 4% ) |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                        |

## Colasa enema 2gm/100mL

| TAH Drug Code      | [ECOL2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ECOL2)                                                                                           |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis, or proctitis                                                                  |
| Dosing             | 2-4 gm (1 to 2 bottles) at night.                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                    |
| Contraindications  | Hypersensitivity to mesalamine, salicylates, or any component of the formulation; severe renal impairment (GFR <30 mL/minute/1.73 m2); severe hepatic impairment |
| Adverse Effects    | Nausea, diarrhea, abdominal pain, headache                                                                                                                       |
| Pregnancy          | Compatible                                                                                                                                                       |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                    |

